Annual Total Liabilities
$12.05 B
+$879.70 M+7.88%
31 December 2023
Summary:
Biogen annual total liabilities is currently $12.05 billion, with the most recent change of +$879.70 million (+7.88%) on 31 December 2023. During the last 3 years, it has fallen by -$1.89 billion (-13.55%). BIIB annual total liabilities is now -13.55% below its all-time high of $13.93 billion, reached on 31 December 2020.BIIB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$11.95 B
+$1.04 B+9.52%
30 September 2024
Summary:
Biogen quarterly total liabilities is currently $11.95 billion, with the most recent change of +$1.04 billion (+9.52%) on 30 September 2024. Over the past year, it has dropped by -$1.76 billion (-12.83%). BIIB quarterly total liabilities is now -15.95% below its all-time high of $14.22 billion, reached on 30 June 2020.BIIB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIIB Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.9% | -12.8% |
| 3 y3 years | -13.6% | -7.5% |
| 5 y5 years | -1.7% | -11.4% |
BIIB Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -13.6% | +7.9% | -12.8% | +11.8% |
| 5 y | 5 years | -13.6% | +7.9% | -15.9% | +11.8% |
| alltime | all time | -13.6% | >+9999.0% | -15.9% | >+9999.0% |
Biogen Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.95 B(+9.5%) |
| June 2024 | - | $10.91 B(-3.9%) |
| Mar 2024 | - | $11.35 B(-5.7%) |
| Dec 2023 | $12.05 B(+7.9%) | $12.05 B(-12.2%) |
| Sept 2023 | - | $13.71 B(+28.2%) |
| June 2023 | - | $10.70 B(-1.1%) |
| Mar 2023 | - | $10.81 B(-3.2%) |
| Dec 2022 | $11.17 B(-13.6%) | $11.17 B(-7.6%) |
| Sept 2022 | - | $12.09 B(-8.6%) |
| June 2022 | - | $13.22 B(+6.7%) |
| Mar 2022 | - | $12.39 B(-4.1%) |
| Dec 2021 | $12.92 B(-7.3%) | $12.92 B(-0.1%) |
| Sept 2021 | - | $12.93 B(-2.5%) |
| June 2021 | - | $13.26 B(+0.5%) |
| Mar 2021 | - | $13.19 B(-5.3%) |
| Dec 2020 | $13.93 B(+0.3%) | $13.93 B(-1.8%) |
| Sept 2020 | - | $14.19 B(-0.2%) |
| June 2020 | - | $14.22 B(+4.7%) |
| Mar 2020 | - | $13.58 B(-2.3%) |
| Dec 2019 | $13.90 B(+13.4%) | $13.90 B(+3.0%) |
| Sept 2019 | - | $13.49 B(+1.2%) |
| June 2019 | - | $13.34 B(+5.7%) |
| Mar 2019 | - | $12.62 B(+3.0%) |
| Dec 2018 | $12.26 B(+10.9%) | $12.26 B(+4.5%) |
| Sept 2018 | - | $11.73 B(+0.3%) |
| June 2018 | - | $11.70 B(-2.9%) |
| Mar 2018 | - | $12.05 B(+9.0%) |
| Dec 2017 | $11.05 B(+2.8%) | $11.05 B(+8.1%) |
| Sept 2017 | - | $10.22 B(+0.4%) |
| June 2017 | - | $10.19 B(+4.7%) |
| Mar 2017 | - | $9.73 B(-9.5%) |
| Dec 2016 | $10.75 B(+6.1%) | $10.75 B(+7.6%) |
| Sept 2016 | - | $9.99 B(-1.2%) |
| June 2016 | - | $10.11 B(-2.3%) |
| Mar 2016 | - | $10.35 B(+2.1%) |
| Dec 2015 | $10.13 B(+189.4%) | $10.13 B(-0.3%) |
| Sept 2015 | - | $10.16 B(+142.7%) |
| June 2015 | - | $4.19 B(+17.9%) |
| Mar 2015 | - | $3.55 B(+1.4%) |
| Dec 2014 | $3.50 B(+8.0%) | $3.50 B(+6.9%) |
| Sept 2014 | - | $3.27 B(-2.4%) |
| June 2014 | - | $3.35 B(+8.5%) |
| Mar 2014 | - | $3.09 B(-4.7%) |
| Dec 2013 | $3.24 B(+2.4%) | $3.24 B(+3.8%) |
| Sept 2013 | - | $3.12 B(+6.3%) |
| June 2013 | - | $2.94 B(+4.0%) |
| Mar 2013 | - | $2.83 B(-10.8%) |
| Dec 2012 | $3.17 B(+20.7%) | $3.17 B(+6.7%) |
| Sept 2012 | - | $2.97 B(+2.7%) |
| June 2012 | - | $2.89 B(+3.1%) |
| Mar 2012 | - | $2.81 B(+7.0%) |
| Dec 2011 | $2.62 B(-0.8%) | $2.62 B(+2.1%) |
| Sept 2011 | - | $2.57 B(+0.1%) |
| June 2011 | - | $2.57 B(-2.0%) |
| Mar 2011 | - | $2.62 B(-0.9%) |
| Dec 2010 | $2.64 B(+15.4%) | $2.64 B(+13.7%) |
| Sept 2010 | - | $2.32 B(+1.4%) |
| June 2010 | - | $2.29 B(+1.1%) |
| Mar 2010 | - | $2.27 B(-1.0%) |
| Dec 2009 | $2.29 B(-13.4%) | $2.29 B(-5.7%) |
| Sept 2009 | - | $2.43 B(-4.1%) |
| June 2009 | - | $2.53 B(-0.9%) |
| Mar 2009 | - | $2.55 B(-3.4%) |
| Dec 2008 | $2.65 B(-14.5%) | $2.65 B(-4.4%) |
| Sept 2008 | - | $2.77 B(+4.4%) |
| June 2008 | - | $2.65 B(+0.5%) |
| Mar 2008 | - | $2.64 B(-14.8%) |
| Dec 2007 | $3.09 B(+120.6%) | $3.09 B(+9.6%) |
| Sept 2007 | - | $2.82 B(-34.3%) |
| June 2007 | - | $4.30 B(+215.5%) |
| Mar 2007 | - | $1.36 B(-2.9%) |
| Dec 2006 | $1.40 B | $1.40 B(+8.6%) |
| Sept 2006 | - | $1.29 B(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2006 | - | $1.33 B(-3.6%) |
| Mar 2006 | - | $1.38 B(-6.4%) |
| Dec 2005 | $1.48 B(-36.9%) | $1.48 B(-2.7%) |
| Sept 2005 | - | $1.52 B(-0.4%) |
| June 2005 | - | $1.52 B(-33.3%) |
| Mar 2005 | - | $2.28 B(-2.5%) |
| Dec 2004 | $2.34 B(-4.5%) | $2.34 B(+1.3%) |
| Sept 2004 | - | $2.31 B(+0.7%) |
| June 2004 | - | $2.29 B(-0.9%) |
| Mar 2004 | - | $2.31 B(-5.6%) |
| Dec 2003 | $2.45 B(+158.0%) | $2.45 B(+556.4%) |
| Sept 2003 | - | $373.32 M(+13.7%) |
| June 2003 | - | $328.21 M(-8.1%) |
| Mar 2003 | - | $357.21 M(-62.4%) |
| Dec 2002 | $950.00 M(+155.2%) | $950.00 M(+177.9%) |
| Sept 2002 | - | $341.85 M(-5.9%) |
| June 2002 | - | $363.25 M(+3.7%) |
| Mar 2002 | - | $350.38 M(-5.9%) |
| Dec 2001 | $372.21 M(+14.4%) | $372.21 M(+5.7%) |
| Sept 2001 | - | $352.12 M(+5.7%) |
| June 2001 | - | $333.15 M(+2.4%) |
| Mar 2001 | - | $325.23 M(-0.1%) |
| Dec 2000 | $325.45 M(+9.1%) | $325.45 M(-4.8%) |
| Sept 2000 | - | $341.85 M(+7.5%) |
| June 2000 | - | $318.07 M(+17.0%) |
| Mar 2000 | - | $271.82 M(-8.9%) |
| Dec 1999 | $298.44 M(+44.8%) | $298.44 M(+51.1%) |
| Sept 1999 | - | $197.50 M(+4.8%) |
| June 1999 | - | $188.50 M(+3.9%) |
| Mar 1999 | - | $181.40 M(-12.0%) |
| Dec 1998 | $206.10 M(-25.7%) | $206.10 M(-6.2%) |
| Sept 1998 | - | $219.80 M(+2.7%) |
| June 1998 | - | $214.10 M(-13.9%) |
| Mar 1998 | - | $248.70 M(-10.4%) |
| Dec 1997 | $277.53 M(+84.8%) | $277.53 M(+74.1%) |
| Sept 1997 | - | $159.40 M(+9.2%) |
| June 1997 | - | $146.00 M(-1.6%) |
| Mar 1997 | - | $148.40 M(-1.2%) |
| Dec 1996 | $150.20 M(+74.2%) | $150.20 M(+18.9%) |
| Sept 1996 | - | $126.30 M(+9.4%) |
| June 1996 | - | $115.50 M(+27.3%) |
| Mar 1996 | - | $90.70 M(+5.2%) |
| Dec 1995 | $86.22 M(+79.9%) | $86.22 M(+19.8%) |
| Sept 1995 | - | $72.00 M(+16.1%) |
| June 1995 | - | $62.00 M(-2.7%) |
| Mar 1995 | - | $63.70 M(+32.9%) |
| Dec 1994 | $47.93 M(+50.7%) | $47.93 M(-18.2%) |
| Sept 1994 | - | $58.60 M(+78.7%) |
| June 1994 | - | $32.80 M(+11.2%) |
| Mar 1994 | - | $29.50 M(-7.2%) |
| Dec 1993 | $31.80 M(+21.4%) | $31.80 M(+5.0%) |
| Sept 1993 | - | $30.30 M(-15.8%) |
| June 1993 | - | $36.00 M(+60.0%) |
| Mar 1993 | - | $22.50 M(-14.1%) |
| Dec 1992 | $26.20 M(+85.8%) | $26.20 M(+25.4%) |
| Sept 1992 | - | $20.90 M(+52.6%) |
| June 1992 | - | $13.70 M(+19.1%) |
| Mar 1992 | - | $11.50 M(-18.4%) |
| Dec 1991 | $14.10 M(+10.2%) | $14.10 M(+8.5%) |
| Sept 1991 | - | $13.00 M(+9.2%) |
| June 1991 | - | $11.90 M(+15.5%) |
| Mar 1991 | - | $10.30 M(-19.5%) |
| Dec 1990 | $12.80 M(+113.3%) | $12.80 M(+45.5%) |
| Sept 1990 | - | $8.80 M(+25.7%) |
| June 1990 | - | $7.00 M(+20.7%) |
| Mar 1990 | - | $5.80 M(-3.3%) |
| Dec 1989 | $6.00 M(-53.5%) | $6.00 M(-7.7%) |
| Sept 1989 | - | $6.50 M(-49.6%) |
| Dec 1988 | $12.90 M(+0.8%) | $12.90 M(+0.8%) |
| Dec 1987 | $12.80 M(+10.3%) | $12.80 M(+10.3%) |
| Dec 1986 | $11.60 M(+6.4%) | $11.60 M(+6.4%) |
| Dec 1985 | $10.90 M(-39.1%) | $10.90 M(-39.1%) |
| Dec 1984 | $17.90 M | $17.90 M |
FAQ
- What is Biogen annual total liabilities?
- What is the all time high annual total liabilities for Biogen?
- What is Biogen annual total liabilities year-on-year change?
- What is Biogen quarterly total liabilities?
- What is the all time high quarterly total liabilities for Biogen?
- What is Biogen quarterly total liabilities year-on-year change?
What is Biogen annual total liabilities?
The current annual total liabilities of BIIB is $12.05 B
What is the all time high annual total liabilities for Biogen?
Biogen all-time high annual total liabilities is $13.93 B
What is Biogen annual total liabilities year-on-year change?
Over the past year, BIIB annual total liabilities has changed by +$879.70 M (+7.88%)
What is Biogen quarterly total liabilities?
The current quarterly total liabilities of BIIB is $11.95 B
What is the all time high quarterly total liabilities for Biogen?
Biogen all-time high quarterly total liabilities is $14.22 B
What is Biogen quarterly total liabilities year-on-year change?
Over the past year, BIIB quarterly total liabilities has changed by -$1.76 B (-12.83%)